Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- CPRX reported adjusted earnings of 38 cents per share, surpassing estimates. - Total revenues were $98.5 million, driven by product sales including Firdapse and Fycompa. - Year to date, Catalyst shares have fallen 12.4% compared to the industry's decline. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- CPRX reported adjusted earnings of 38 cents per share, surpassing estimates.
- Total revenues were $98.5 million, driven by product sales including Firdapse and Fycompa.
- Year to date, Catalyst shares have fallen 12.4% compared to the industry's decline.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.